Duffy Terrence A's Form 4 filing
CME Group Inc.CME · filed Mar 11, 2025
- Accession no.
- 0001156375-25-000031
- Filed
- Mar 11, 2025
- Trade date
- Mar 11, 2025
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $7.78M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Duffy Terrence ACIK 0001212809 | Director, Officer (Chairman and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2025 | Common Stock Class A | SSaleDisposed | −30,000 | $259.18F1 | −$7,775,400 | 53,205 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
On March 11, 2025, Mr. Duffy sold an aggregate of 30,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $259.00 to $259.26. The Company maintains a record of the transaction and copies will be provided upon request.
Referenced by the price of 1 transaction in Table I.